Potassium channelopathies

Neuropharmacology. 1997 Jun;36(6):755-62. doi: 10.1016/s0028-3908(97)00029-4.

Abstract

The molecular diversity of K(+)-selective channels far exceeds any other group of voltage- or ligand-gated channels, reflecting their early ancestral origin. This diversity is mirrored by the broad spectrum of physiological functions subserved by these proteins. Potassium channels modulate the resting potential and action potential duration of neurons, myocytes and endocrine cells and stabilize the membrane potential of excitable and nonexcitable cells. In addition to channel diversity, differential cellular expression of K+ channels determines the specific electrical responses to stimuli in a particular cell or tissue. This study reviews the recent genetic and physiological studies of congenital disorders caused by mutations in genes encoding K+ channels. These include the human disorders of episodic ataxia with myokymia, long QT syndrome and Bartter's syndrome, and weaver ataxia in mice. An understanding of the molecular basis of these diseases could facilitate the discovery and development of specific pharmacological therapies.

Publication types

  • Review

MeSH terms

  • Action Potentials
  • Animals
  • Arrhythmias, Cardiac / genetics
  • Ataxia / genetics
  • Bartter Syndrome / genetics
  • Humans
  • Membrane Potentials
  • Mice
  • Mice, Neurologic Mutants
  • Mutation
  • Potassium Channels / genetics*
  • Potassium Channels / physiology

Substances

  • Potassium Channels